Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.

Frontiers Immune Evasive Effects of SARS-CoV-2 Variants to COVID

Cross-variant protection against SARS-CoV-2 infection in hamsters

Intranasal administration of convalescent plasma protects against

Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but

Immune memory from SARS-CoV-2 infection in hamsters provides

Infection- or AZD1222 vaccine-mediated immunity reduces SARS

COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2

S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral

Two Years into the COVID-19 Pandemic: Lessons Learned

Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures

Vaccines, Free Full-Text

SARS-CoV-2 viral load and shedding kinetics

Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2

Cross protection to SARS-CoV-2 variants in hamsters with naturally

Immune memory from SARS-CoV-2 infection in hamsters provides